Medlumics is developing new medical devices for the treatment of Cardiac Rhythm Disturbances.
A pre-commercial device company, it designs and manufactures catheter-based systems for the treatment of supra-ventricular tachycardias.
Copyright © 2023 Seroba. All rights reserved.
Legal | Privacy | Sustainability
Location: Canada, Ontario, Ottawa
Employees: 11-50
Total raised: $85.21M
Founded date: 2009
Investors 7
Funding Rounds 5
| Date | Series | Amount | Investors |
| 10.02.2021 | - | $21.84M | - |
| 22.03.2017 | Series B | $37.12M | - |
| 25.03.2014 | - | $4.98M | - |
| 01.12.2011 | Series A | $4.72M | - |
| - | Series E | $16.56M | Asabys Par... |
Mentions in press and media 20
| Date | Title | Description | Source |
| 11.02.2021 | MedLumics cierra una ronda de €18M a la que acuden Kurma Par... | 11/02/2021 Nota de prensa MEDLUMICS CIERRA UNA RONDA DE €18 MILLONES. PARTICIPAN, ENTRE OTROS, KUR... | webcapital... |
| 10.02.2021 | MedLumics closes upsized EUR 18M (21.7M USD) financing round... | MedLumics’ oversubscribed financing round closes at EUR 18M to advance optically-guided real-time ab... | asabys.com... |
| 10.02.2021 | MedLumics raises $21.8M to test its optically guided heart a... | MedLumics has raised €18 million, or about $21.8 million, to move toward clinically proving its opti... | fiercebiot... |
| 10.02.2021 | MedLumics closes upsized EUR 18M financing round and appoint... | Madrid, Spain, [10 February 2021] – MedLumics, a privately held medical device company developing ... | anderapart... |
| 10.02.2021 | MedLumics raises $21.8M to test its optically guided heart a... | MedLumics has raised €18 million, or about $21.8 million, to move toward clinically proving its opti... | fiercebiot... |
| 10.02.2021 | MedLumics Closes Upsized EUR 18M Financing Round | MedLumics, a Madrid, Spain-based medical device company developing an optically-guided real-time abl... | finsmes.co... |
| 09.10.2020 | Medlumics cierra una ronda de financiación de €14M co-lidera... | Medlumics, desarrollador de Ablaview®, un sistema de ablación cardiaca por radiofrecuencia irrigada ... | caixacapit... |
| 09.10.2020 | Medlumics raises €14M in a Series E financing co-led by Asab... | Medlumics, which develops Ablaview®, a unique RF irrigated ablation catheter system that merges phot... | caixacapit... |
| 08.10.2020 | Medlumics cierra una ronda de €14M co-liderada por Asabys Pa... | 08/10/2020 Nota de prensa MEDLUMICS CIERRA UNA RONDA DE €14M CO-LIDERADA POR ASABYS PARTNERS, VI P... | webcapital... |
| 17.09.2019 | Madrid Invests in Innovation and Infrastructure to Attract S... | As the capital and largest city in Spain, Madrid has historically had a large role in shaping Europe... | startupgen... |
Show more